UC Faculty Member Winner of Stroke Leadership Prize
CINCINNATIMatthew Flaherty, MD, assistant professor of neurology at the University of Cincinnati (UC), is being awarded the 2009 Michael S. Pessin Stroke Leadership Prize for his research in stroke treatment.
Flaherty will receive the award during the 61st annual meeting of the
Flaherty is being recognized for his research accomplishments, including leadership of the Spot Sign for Predicting and Treating Intracerebral Hemorrhage Growth Study (STOP-IT Study), which was designed to find a better way of selecting stroke patients for treatment. The study includes a test to help doctors predict which patients who suffer a stroke with bleeding in the brain will experience further bleeding which can cause additional injury. Patients will be given either a fast-acting drug to stop bleeding or a placebo as part of the study.
While there are no proven, effective treatments for intracerebral hemorrhage, the model being evaluated in the STOP-IT Study may eventually lead to a medical treatment that improves outcomes for stoke patients, says Flaherty.
The Michael S. Pessin Stroke Leadership Prize is sponsored by the AAN and endowed by the family, friends and colleagues of Dr. Pessin, who died in 1996.
The
Tags
Related Stories
New UC Center for Alzheimer's and Neurodegenerative Diseases Research to advance dementia research, treatment and education
July 14, 2026
The University of Cincinnati and UC Health are launching the Center for Alzheimer's and Neurodegenerative Diseases Research (CANDR) to advance dementia research, clinical care and brain health education.
UC students organize free health clinic in community
July 13, 2026
The University of Cincinnati student chapter of Remote Area Medical held its annual free health clinic July 11-12 at St. Xavier High School. Medical, dental and vision care was offered to adults and children, with no income requirements or insurance needed.
Is speech-to-text AI really reliable?
July 10, 2026
UC researcher Nelly Elsayed’s study in the International Journal of Medical Informatics reveals key risks in clinical speech-to-text AI and shows why human review is essential.